IL-25 Enhances HSV-1 replication by inhibiting filaggrin expression, and acts synergistically with TH2 cytokines to enhance hsv-1 replication

Journal of Investigative Dermatology

Volumn 133, Issue 12, 2013, Pages 2678-2685

  Kim, Byung Eui ^a   Bin, Lianghua ^a   Ye, Young Min ^a,b   Ramamoorthy, Preveen ^a   Leung, Donald Y M ^a,c  

^a DEPARTMENT OF MEDICINE   (United States)

^b Ajou University School of Medicine   (South Korea)

^c Children's Hospital Colorado   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CYTOKINE; FILAGGRIN; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 25; INTERLEUKIN 4; MESSENGER RNA;

ARTICLE; ATOPIC DERMATITIS; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE MUTATION; GENE SILENCING; GENOTYPE; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; KAPOSI VARICELLIFORM ERUPTION; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PSORIASIS; SKIN BIOPSY; TH2 CELL; UPREGULATION; VACCINIA VIRUS; VIRUS REPLICATION;

EID: 84887823825     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2013.223     Document Type: Article

References (29)

1. Albanesi C, Fairchild HR, Madonna S et al. (2007) IL-4 and IL-13 negatively regulate TNF-alpha-and IFN-gamma-induced beta-defensin expression through STAT-6, suppressor of cytokine signaling (SOCS)-1, and SOCS-3. J Immunol 179:984-92
2. Barlow JL, Flynn RJ, Ballantyne SJ et al. (2011) Reciprocal expression of IL-25 and IL-17A is important for allergic airways hyperreactivity. Clin Exp Allergy 41:1447-55
3. Beck LA, Boguniewicz M, Hata T et al. (2009) Phenotype of atopic dermatitis subjects with a history of eczema herpeticum. J Allergy Clin Immunol 124:260-9. 269 e261-267
4. Bieber T (2010) Atopic dermatitis. Ann Dermatol 22:125-37
5. Christophers E, Henseler T (1987) Contrasting disease patterns in psoriasis and atopic dermatitis. Arch Dermatol Res 279(Suppl):S48-51
6. Fort MM, Cheung J, Yen D et al. (2001) IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 15:985-95
7. Gao PS, Rafaels NM, Hand T et al. (2009) Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticum. J Allergy Clin Immunol 124:507-13. 513 e501-507
8. Geha RS, Oyoshi MK (2012) Filaggrin deficiency impairs viral containment in mice cutaneously inoculated with vaccinia virus (VV). J Allergy Clin Immunol 129:AB37
9. Hamid Q, Boguniewicz M, Leung DY (1994) Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest 94:870-6
10. Howell MD, Boguniewicz M, Pastore S et al. (2006a) Mechanism of HBD-3 deficiency in atopic dermatitis. Clin Immunol 121:332-8
11. Howell MD, Gallo RL, Boguniewicz M et al. (2006b) Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus. Immunity 24:341-8
12. Howell MD, Gao P, Kim BE et al. (2011) The signal transducer and activator of transcription 6 gene (STAT6) increases the propensity of patients with atopic dermatitis toward disseminated viral skin infections. J Allergy Clin Immunol 128:1006-14
13. Howell MD, Kim BE, Gao P et al. (2009) Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol 124:R7-12
14. Howell MD, Streib JE, Leung DY (2007) Antiviral activity of human beta-defensin 3 against vaccinia virus. J Allergy Clin Immunol 119: 1022-5
15. Howell MD, Wollenberg A, Gallo RL et al. (2006c) Cathelicidin deficiency predisposes to eczema herpeticum. J Allergy Clin Immunol 117:836-41
16. Hvid M, Vestergaard C, Kemp K et al. (2011) IL-25 in atopic dermatitis: a possible link between inflammation and skin barrier dysfunction J Invest Dermatol 131:150-7
17. Irvine AD, McLean WH, Leung DY (2011) Filaggrin mutations associated with skin and allergic diseases. N Engl J Med 365:1315-27
18. Kezic S, ORegan GM, Lutter R et al. (2012) Filaggrin loss-of-function mutations are associated with enhanced expression of IL-1 cytokines in the stratum corneum of patients with atopic dermatitis and in a murine model of filaggrin deficiency. J Allergy Clin Immunol 129: 1031-39
19. Kim BE, Howell MD, Guttman-Yassky E et al. (2011) TNF-alpha downregulates filaggrin and loricrin through c-Jun N-terminal kinase: role for TNF-alpha antagonists to improve skin barrier. J Invest Dermatol 131:1272-9
20. Kim BE, Leung DY (2012) Epidermal barrier in atopic dermatitis. Allergy Asthma Immunol Res 4:12-6
21. Kim BE, Leung DY, Boguniewicz M et al. (2008) Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6. Clin Immunol 126:332-7
22. Lee J, HoWH, Maruoka M et al. (2001) IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1. J Biol Chem 276:1660-4
23. Leung DY, Gao PS, Grigoryev DN et al. (2011) Human atopic dermatitis complicated by eczema herpeticum is associated with abnormalities in IFN-gamma response. J Allergy Clin Immunol 127:965-73
24. Miajlovic H, Fallon PG, Irvine AD et al. (2010) Effect of filaggrin breakdown products on growth of and protein expression by Staphylococcus aureus. J Allergy Clin Immunol 126:1184-190 e1183
25. Nomura I, Goleva E, Howell MD et al. (2003) Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol 171:3262-9
26. ORegan GM, Sandilands A, McLean WH et al. (2008) Filaggrin in atopic dermatitis. J Allergy Clin Immunol 122:689-93
27. Rosenthal KS, Killius J, Hodnichak CM et al. (1989) Mild acidic pH inhibition of the major pathway of herpes simplex virus entry into HEp-2 cells. J Gen Virol 70(Pt 4):857-67
28. Sehra S, Yao Y, Howell MD et al. (2010) IL-4 regulates skin homeostasis and the predisposition toward allergic skin inflammation. J Immunol 184:3186-90
29. Zheng T, Yu J, Oh MH et al. (2011) The atopic march: progression from atopic dermatitis to allergic rhinitis and asthma. Allergy Asthma Immunol Res 3:67-73